/Companies

Tmunity Therapeutics

Acquired

Philadelphia, US · Founded 2015 · Delaware corporation · 7 known investors

Find your way into Tmunity Therapeutics

Sign up to see every warm intro you have to Tmunity Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tmunity Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Acquired by Kite Pharma (Gilead Sciences) December 2022 · terms undisclosed — Undisclosed · source ↗

Tmunity Therapeutics was a University of Pennsylvania spinout developing engineered T-cell therapies, including CAR-T and TCR-based treatments, for cancers.

Founders & leadership

Tmunity Therapeutics was founded in 2015 by Anne Chew.

AC
Anne ChewDirector and President

Board

KM
Kevin MahoneyBoard director

Investors · 7

Reported raises · per SEC filings

Form D private placements

$175M disclosed across 5 rounds · 2015–2019

▶$75MraisedOct 2019 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • PATRICK GRAYDirector
  • GARRY NICHOLSONDirector
  • USMAN AZAMExecutive Officer, Director
  • YAN ZHANGDirector
  • JASON KRENTZExecutive Officer
  • MOJI JAMESExecutive Officer
  • CHRISTINA COUGHLINExecutive Officer
  • GRAEME BELLExecutive Officer
  • JUDITH LIDirector
  • MICHAEL CHRISTIANOExecutive Officer
  • BETH SEIDENBERGDirector
  • SEAN PARKERDirector
Offering amount
$75M
Amount sold
$75M
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$85MraisedMay 2018 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JUDITH LIDirector
  • MICHAEL CHRISTIANOExecutive Officer
  • USMAN AZAMExecutive Officer
  • JIANG ZHANGDirector
  • SEAN PARKERDirector
  • KEVIN MAHONEYDirector
  • ALESSANDRO RIVADirector
Offering amount
$85M
Amount sold
$85M
First sale
Jan 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJan 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MICHAEL CHRISTIANOExecutive Officer
  • USMAN AZAMExecutive Officer
  • KEVIN MAHONEYDirector
  • ANNE CHEWDirector
Offering amount
$5M
Amount sold
$5M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedFeb 2016 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin MahoneyDirector
  • Anne ChewExecutive Officer, Director
Offering amount
$5M
Amount sold
$5M
First sale
Jan 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedDec 2015 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Anne ChewExecutive Officer, Director
Offering amount
$5M
Amount sold
$5M
First sale
Dec 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Tmunity Therapeutics do?
Tmunity Therapeutics was a University of Pennsylvania spinout developing engineered T-cell therapies, including CAR-T and TCR-based treatments, for cancers.
Who founded Tmunity Therapeutics?
Tmunity Therapeutics was founded by Anne Chew in 2015.
Who are Tmunity Therapeutics's investors?
Tmunity Therapeutics's investors include Andreessen Horowitz, Khosla Ventures, Kleiner Perkins, LAV, Lilly Asia Ventures, Militia Hill Ventures, Gilead Sciences.
How much funding has Tmunity Therapeutics raised?
Tmunity Therapeutics has disclosed $175M raised across 5 rounds.
Where is Tmunity Therapeutics headquartered?
Tmunity Therapeutics is headquartered in Philadelphia, US.